A Real-world Clinical Study on Effectiveness and Safety of Long-term TAF Treatment in Chronic Hepatitis B Patients in China
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2019
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms TRUE
- 23 Jan 2019 Planned primary completion date changed from 1 Dec 2022 to 31 Dec 2022.
- 23 Jan 2019 Planned initiation date changed from 1 Dec 2018 to 1 Feb 2019.
- 30 Nov 2018 New trial record